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Abstract
Background: The neurotransmitter serotonin (5-HT) has been linked to the underlying neurobiology of aggressive behavior,
particularly with evidence from studies in animals and humans. However, the underlying neurobiology of aggression
remains unclear in the context of attention-deficit/hyperactivity disorder (ADHD), a disorder known to be associated with
aggression and impulsivity. We investigated the effects of acute tryptophan depletion (ATD), and the resulting diminished
central nervous serotonergic neurotransmission, on reactive aggression in healthy controls and adults with ADHD.
Methodology/Principal Findings: Twenty male patients with ADHD and twenty healthy male controls were subjected to
ATD with an amino acid (AA) beverage that lacked tryptophan (TRP, the physiological precursor of 5-HT) and a TRP-
balanced AA beverage (BAL) in a double-blind, within-subject crossover-study over two study days. We assessed reactive
aggression 3.25 hours after ATD/BAL intake using a point-subtraction aggression game (PSAG) in which participants played
for points against a fictitious opponent. Point subtraction was taken as a measure for reactive aggression. Lowered rates of
reactive aggression were found in the ADHD group under ATD after low provocation (LP), with controls showing the
opposite effect. In patients with ADHD, trait-impulsivity was negatively correlated with the ATD effect on reactive
aggression after LP. Statistical power was limited due to large standard deviations observed in the data on point
subtraction, which may limit the use of this particular paradigm in adults with ADHD.
Conclusions/Significance: Together with previous findings, the data provide preliminary evidence of an inverse association
between trait-impulsivity and the ATD effect on reactive aggression after LP (as assessed by the PSAG) in patients with
ADHD and that this relationship can be found in both adolescents and adults. Because of limited statistical power larger
sample sizes are needed to find main effects of ATD/BAL administration on reactive aggression in adults with ADHD.
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Introduction
Recent research has shown that symptoms related to attention-
deficit hyperactivity disorder (ADHD), a disorder predominantly
linked to changes in catecholaminergic neurotransmission, are also
affected by variation in serotonin-related genes [1,2,3,4]. There is
a considerable body of evidence showing that neurobiological and
environmental factors significantly contribute to disorders and
phenotypes associated with aggression and impulsivity [2,4]. The
neurotransmitter serotonin (5-HT) has been linked to the
neurobiological underpinnings of aggressive behavior by a
considerable body of animal research, suggesting that low central
nervous system 5-HT activity is associated with aggression and
impulsivity [5,6,7].
A considerable amount of studies investigated the effects of
changes in serotonergic neurotransmission on aggression in
rodents. Evidence suggests that reduced serotonin-mediated
inhibition facilitates aggressive behavior [8]. Moreover, prolonged
TRP deprivation lead to increased killing of mice in rats when
compared to standard foods that were administered to the animals
PLoS ONE | www.plosone.org 1 March 2012 | Volume 7 | Issue 3 | e32023[9]. However, the data of this particular study also suggested that
mouse-killing persisted after rats were returned to standard food,
indicating that reduced serotonergic neurotransmission did not
influence the maintenance of aggression [9]. In addition, research
using the selective and irreversible TPH2 inhibitor p-chlorophe-
nylalanine (PCPA) indicated that depletion of central nervous
serotonin function in rats increased nonspecific killing reactions
but was insufficient as regards species-specific predatory behavior
[10]. Forebrain structures and depletion of serotonin function by
the neurotoxin 5,7-dihydroxytryptamine (5,7-DHT) in these brain
areas were shown to be of particular relevance [11]. Finally, a
further study using PCPA administration in rats showed that only
minimal impairments as regards serotonin modulated inhibitory
control resulted in muricidal aggression in rats of both sexes that
was related to a depletion in central nervous serotonin function of
approximately 55–60% [12]. Overall, the relationship between
reduced central nervous serotonin synthesis achieved by different
depletion techniques in rats and increased aggression is a rather
robust finding [8,9,10,11,12,13,14,15,16]. Early acute tryptophan
depletion (ATD) studies that were conducted in rats indicated
significant effects on a diminished 5-HT synthesis [13,17,18].
A number of behavioral studies in humans have used the ATD
technique to investigate impulsive and aggressive behavior after
the central nervous 5-HT synthesis rate has been experimentally
depleted [19,20,21,22,23]. Studies have used modifications of the
‘‘Point Subtraction Aggression Paradigm’’ (PSAP) [24] to assess
reactive aggressive behavior under depleted and sham-depleted
conditions. Several studies have detected increased aggression
during diminished central nervous synthesis of 5-HT in healthy
(mostly male) subjects [21,22,25]. However, ATD has also been
shown to decrease aggression in nonaggressive men [21]. Salomon
and colleagues found that that ATD did not affect aggression as
assessed by the Buss-Durkee Hostility-Guilt Inventory and the
Overt Aggression Scale (OAS) [26]. Moreover, LeMarquand and
coworkers also did not detect a relationship between acutely
diminished central nervous 5-HT synthesis and aspects of
impulsive [27,28] or impulsive and aggressive behavior [28] in
either young adults with a family history of alcoholism [28] or in
young, aggressive males [27] using a modified Taylor task [28] and
a go/no-go learning task [27,28]. Of note, the negative findings of
LeMarquand et al. in their study of young, aggressive males was
possibly due to a ceiling effect [27]; a subsequent study found a
group-specific effect. Using a behavioral measure, only high-
aggressive subjects showed increased aggression after ATD; low
aggressive subjects showed no difference. Overall, both group-
specific [20,21,22,26,29,30] and task-related characteristics
[27,28] must be taken into account to explain the currently
available results (for an overview, see [31]).
There is a scarcity of data on the relationship between 5-HT
function and aggression in children and adolescents. Studying the
developmental trajectory of reactive aggression in relation to
clinical phenotypes is highly relevant to understanding the
development of neuropsychiatric disorders associated with high
levels of aggression and violence [32,33]. Behavioral findings have
shown that low-impulsive children and adolescents with ADHD
behave in a highly impulsive and aggressive manner when
subjected to ATD [34]. However, there are no studies to date
that have investigated the effects of ATD on reactive aggression in
adult patients with ADHD, a disorder that frequently presents
with co-morbid aggression and behavioral problems.
In the present study, we investigated the effects of ATD
compared with a tryptophan-(TRP)-balanced control condition
(TRP balanced amino acid load, BAL) on reactive aggression,
which we assessed with the Point-Subtraction Aggression Game
(PSAG, using high provocation [HP] and low provocation [LP]
trials) in a sample of male patients with ADHD and healthy
controls.
Results
Between-group comparison
A 2 (group: ADHD vs. controls)62 (treatment: ATD vs.
BAL)62 (provocation: HP vs. LP) repeated measures analysis of
variance (RMANOVA) showed a significant group-by-treatment
interaction (p=0.017, F=6.256, df=1, 39). Post-hoc analyses
indicated that in patients, fewer points were subtracted in the LP
condition during ATD than during BAL (t=2.341, p=0.030,
df=1, 19; see Fig. 1a). For the HP condition, we did not detect
such a difference (t=1.241, p=n.s., df=1, 19). In the group of
healthy controls, more points were subtracted in the LP condition
during ATD than during BAL (t=2.382, p=0.028, df=1, 19, see
Fig. 1b). For the HP condition, we did not find such a difference
(t=1.318, p=n.s., df=1, 19). Participants in both groups
subtracted more points in the HP condition than in the LP
condition (p=0.000, F=49.551, df=1, 39). Subjects with a
combined (n=13) or inattentive (n=7) subtype of ADHD did not
differ in the ATD effect on point subtraction as a function of
provocation (LP/HP) or treatment (ATD/BAL) (RMANOVA
with no significant treatment [ATD vs. BAL]6 sub-group
interaction p=n.s., F=0.940, df=1, 39).
Dimensional analysis
In the patient group, there was a significant negative correlation
between the ATD effect on point subtraction (ATD minus BAL,
hereafter D) in the PSAG after low provocation (DLP) and baseline
impulsivity scores as indexed by the Barratt Impulsiveness Scale
(BIS) Motor Impulsiveness subscale (MI; Rho=20.506; p=0.023),
and MI explained approximately 25.6% of the shared intraindi-
vidual variance. DLP was also negatively correlated with the total
impulsivity scale (TI; Rho=20.448; p=0.048), and explained
approximately 20.1% of the shared intraindividual variance. The
correlation between DLP and unplanned impulsivity (UI;
Rho=20.379; p=n.s.) and cognitive impulsiveness (CI;
Rho=20.148; p=n.s.) was not significant. In the control group,
we found no such correlations with DLP (MI: Rho=20.188,
p=n.s., UI: Rho=20.184, p=n.s.; CI: Rho=20.275, p=n.s.; TI:
Rho=20.300; p=n.s.) or DHP (MI: Rho=20.212, p=n.s., UI:
Rho=20.155, p=n.s.; CI: Rho=20.132, p=n.s.; TI:
Rho=20.145; p=n.s.).
Discussion
To our knowledge, this is the first study to investigate the effects
of ATD on reactive aggression in adult patients with ADHD
compared with healthy adult controls. Both groups subtracted
more points after HP than LP regardless of ATD/BAL intake,
which is consistent with the concept of PSAG, the behavioral
paradigm used to assess aggressive behavior. Patients with ADHD
subtracted fewer points under ATD than BAL in the LP condition,
but the HP condition showed no difference. This effect was not
found in our previous study of children and adolescents with
ADHD [34], suggesting a potential developmental difference in
the total number of points subtracted under depletion conditions.
However, in the subgroup of patients with ADHD, there was a
negative correlation between trait-impulsivity scores (in particular
motor impulsivity) and DLP, which is consistent with the data we
have previously obtained in children and adolescents with ADHD
[34]. This finding is of particular relevance as it suggests that both
Serotonin and Aggression in ADHD
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respond with increased reactive aggression under ATD after a low
provocation [32]. In addition, low-impulsive patients in particular
showed a lowered heart rate under ATD [35] while behaving
aggressively [34]. This is consistent with previous findings showing
that the low provocation condition in the used behavioral paradigm
is the most effective to assess anger reactive responses [36,37]. A
negative correlation was found between baseline aggression scores
and the ATD effect on extraversion ratings of a fictitious opponent
in adolescents with ADHD, which supports the idea that there is an
inverse association between changes in 5-HT neurotransmission
and impulsivity/aggression-related behavioral traits [38]. From this,
one could conclude that low-impulsivity patients with ADHD are
particularly susceptible to an increase in reactive aggression when
the central nervous 5-HT synthesis rate is diminished.
The present study has several significant advantages over
previous research. First and foremost, apart from the double-blind
within-subject repeated measures design it included a healthy
control group that did not differ from the patients in education, IQ
or age, which was not possible in previous research [34,39,40,41].
Second, using the same behavioral paradigm as previous research
with children and adolescents allows us to look at the behavioral
data from a developmental viewpoint as part of an iterative
approach that focuses on the neurobiological underpinnings of
anger reactive aggression in ADHD. Moreover, the same
neurochemical depletion procedure (ATD Moja-De) was used as
in studies on children and adolescents [34]. In addition, the used
depletion paradigm ATD Moja-De takes the body weight of the
subjects as well as their baseline TRP into account (as there are
correlations between body weight and baseline tryptophan, see
[42]), resulting in improved tolerability and allowing its use in
children and adolescents. Finally, the administration of ATD/BAL
was designed as a within-subject repeated measures factor in a
double-blind setting, allowing sufficient statistical power to detect
significant differences in mean point subtraction in the PSAG
under ATD between the two groups. Cohen’s d values as an
estimate for effect sizes were moderate as regards the difference in
mean point subtraction under ATD between the two groups.
There are some methodological considerations to be aware of
when trying to interpret data related to reactive aggression
obtained using the PSAG under ATD/BAL. First and foremost,
the PSAG task as used in the present study did not allow the
participants to not behave aggressively [31,34]. In particular, as
regards HP trials in terms of a ceiling effect subjects might have felt
to have to subtract as many points as their opponent did, whereas
for the LP condition there was a greater range to over-respond or
overreact to the received provocation. This is in line with past
research using the PSAG and its modifications, indicating that the
LP condition is particularly sensitive to assess an ager reactive
response [36,37]. Second, using the adapted version for adoles-
cents in adults might have caused altered response patterns (as
indicated by the rather large standard deviations in the PSAG data
in the adult subjects). However, this finding is of value for future
research aiming to use behavioral paradigms to assess aggressive
behavior in both youths and adults from a developmental
viewpoint. As elucidated by the present study further research
on the validity of using this particular version of the PSAG in
adults is warranted. Third, a drawback to the study is that there
are no data from females, which questions whether the results
would be found in female patients with ADHD. This concern is
relevant because past research has indicated that there are
significant differences in 5-HT brain synthesis between males
and females [43]. Moreover, genetic data regarding the serotonin
system were not obtained, which would have resulted in significant
larger sample sizes. Further research with significantly larger
samples is warranted to detect whether variation in genes linked to
serotonergic neurotransmission impact reactive aggression assessed
under a diminished central nervous 5-HT synthesis rate.
In summary, the present data provide supporting preliminary
evidence for an inverse association between measures of trait-
impulsivity and the ATD effect on reactive aggression in patients
with ADHD, and this relationship can be found in adolescents and
adults. However, sample size was too small in order to be able to
find significant main effects of the factor ATD/BAL on reactive
aggression in adult patients with ADHD. More research on the
laboratory assessment of reactive aggression in adults using the
PSAG and studies involving females are needed.
Materials and Methods
Sample
We recruited twenty adult male patients with a confirmed
diagnosis of ADHD (using DSM-IV criteria) from the outpatient
Figure 1. Fig. 1a. Mean point subtraction with standard deviation
after low (LP) and high provocation (HP) in a point-subtraction
aggression game. Data were obtained during a period of a diminished
central nervous serotonin synthesis rate (Acute tryptophan depletion,
ATD) and a control condition (Tryptophan balanced amino acid load,
BAL). Significant relationships are indicated by * (p,0.05). Fig. 1b.
Mean point subtraction with standard deviation after low (LP) and high
provocation (HP) in a point-subtraction aggression game. Data were
obtained during a period of a diminished central nervous serotonin
synthesis rate (Acute tryptophan depletion, ATD) and a control
condition (Tryptophan balanced amino acid load, BAL). Significant
relationships are indicated by * (p,0.05).
doi:10.1371/journal.pone.0032023.g001
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University of Duisburg-Essen. The diagnosis of ADHD in each
patient was also confirmed using the Wender Utah Rating Scale
(WURS, [44]). Thirteen patients were diagnosed with the
combined ADHD subtype and seven patients were diagnosed
with the inattentive subtype. Other psychiatric disorders, such as
co-morbid depression and mood disorders or substance abuse, as
well as the current use of psychotropic medications other than
methylphenidate (MPH) were exclusion criteria. They were ruled
out by interview and anxiety symptoms were ruled out using the
German Version of the State-Trait Anxiety Inventory [45].
Twenty healthy adult male controls were recruited from various
university and non-university settings. No participant had a history
of obesity, asthma, diabetes, substance abuse, psychotic disorders,
or neurological diseases. During testing, patients were free from all
medication. MPH (n=16 patients) was not taken for one day
before each study day, or two days prior to the study day in the
case of patients prescribed long-acting MPH-based formulations.
On both study days, participants were asked before they
participated to confirm they had not taken their MPH medication.
Participants also had to confirm that they did not take any other
recreational drugs. Between the two study days, MPH was taken as
prescribed. As regards medication history, one patient took
atomoxetine before the study but medication was stopped several
weeks before participation in the trial. One patient took an
antidepressant (SSRI) before the trial and treatment was stopped
several weeks before the study. Two patients had received a
combination of MPH and antidepressants (SSRI/SNRI), and
antidepressive treatment was stopped several weeks before
participation. All patients were instructed not to consume caffeine
or nicotine on study days, and regular heavy smokers (.8
cigarettes per day) were excluded from the study. We assessed
cognitive abilities with the Wechsler Adult Intelligence Scale (3
rd
edition), and found no significant group differences (p=n.s.,
t=26.098, F=4.972, df=1, 38; see Table 1). No subject was
accepted with an IQ below 75. A complete study description was
handed out to all participants, and informed written and verbal
consent were obtained. The study was assessed and approved by
the Ethics Commission of the Faculty of Medicine of the
University Duisburg-Essen, and was carried out in accordance
with the Declaration of Helsinki.
Study design
The study used a double-blind within-subject crossover design.
ATD/BAL amino acid (AA) administration was randomized and
counterbalanced. In accordance with Moja and colleagues [46],
subjects received an AA beverage lacking TRP (the ATD
condition), which was modified for the impact of body weight
[31,34,47], on one day. On another day, they received a TRP-
balanced amino acid load (BAL) as a control condition (sham
depletion). Testing days were spaced seven days apart. In both
groups, ten participants received the ATD beverage on the first
day of the study, and ten participants received it on the second.
Both the patients and the investigator were blind to the order of
ATD/BAL administration. On each testing day, 3.25 hours after
administration of ATD/BAL (time point of approx. 90%
reduction in 5-HT synthesis rate, see [42]), patients were
administered the Point Subtraction Aggression Game (PSAG), a
task designed to provoke reactive aggressive behavior. The PSAG
has been employed in previous research on children and
adolescents with ADHD to assess anger reactive aggression
[34,37]. Subjects were debriefed after completing the study.
Depletion procedure
Subjects were required to maintain a protein-free diet after 8
p.m. on the day before each testing session. The AA mixtures for
the two conditions looked optically identical. We used a fixed
standardized version for a normal body weight of 80 kg in
accordance with the Moja-De ATD protocol [48]. The AAs were
mixed with 150 ml of water prior to administration. Immediately
after intake of ATD/BAL, subjects were given a multivitamin
candy to counteract the AA mixture’s sour taste. One hour after
ATD/BAL administration, all participants received a multi-
vitamin beverage containing 30% of the recommended daily dose
of nicotine adenine dinucleotide, which is a TRP-derived vitamin
[47].
Assessment of trait-impulsivity
Motor Impulsiveness (MI), Cognitive Impulsiveness (CI) and
Nonplanning Impulsiveness (NI), as well as total impulsivity (TI),
were assessed using the Barratt Impulsiveness Scale (BIS) on the
first day of the study [49].
Assessment of reactive aggression
The Point Subtraction Aggression Game (PSAG) is a modified
version of the PSAP [24] that was developed for use in patients
with disruptive behavior disorders [37]. In this task, subjects
compete for points with a fictitious opponent of the same gender.
We told subjects that they would be playing against a clinic staff
member who was sitting in a different room of the building and
that his computer was linked to the subject’s computer via a local
area network (LAN). The investigator called the staff member by
phone to clarify relevant details for playing the game via LAN,
such as the subject’s identity number, etc.
The task was to react to a visually presented stimulus faster than
the opponent by pressing a computer button. The stimulus was a
soccer ball, and it appeared in a randomized order from different
locations of the computer screen. To increase the difficulty, the
Table 1. The characteristics of the study sample (a group of patients with attention-deficit/hyperactivity disorder (ADHD) and a
group of healthy controls).
Patients with ADHD (n=20) Healthy controls (n=20)
M ± SD Min. Max. M ± SD Min. Max. p
Age 30.2569.37 19 46 27.9066.02 20 46 n.s.
IQ 108615.875 77 130 109610.65 96 136 n.s.
Education (yrs) 13.9063.40 8 20 15.2562.83 10 21 n.s.
Age on the first day of the study, IQ (as assessed by the Wechsler Adult Intelligence Scale [3rd edition]), and years of formal education. Mean values were compared,
using two-tailed t-tests, to identify significant differences between adult patients with ADHD and healthy adult controls.
doi:10.1371/journal.pone.0032023.t001
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the stimulus was also randomized. The subject was instructed to
achieve a high score at the end of the game. He was awarded 50
points on winning trials and had 50 points subtracted on losing
trials. Additionally, the opponent had the opportunity to subtract
between 0 and 100 points in steps of 10 points from the subject if
he lost a trial. Conversely, if the subject won a trial, he could
deduct between 0 and 100 points from his opponent. Winning and
losing trials were predetermined within the game, and the
sequence of winning and losing trials was the same on both
testing days.
The dependent variable was the number of points that the
subject deducted from his opponent after being provoked with a
subtraction of a certain number of points by the opponent. The
level of provocation was defined by the number of points the
opponent subtracted from the subject. A high-provocation (HP)
level was defined as an 80 to 100 point subtraction, and a low-
provocation (LP) level was defined as a 20 to 40 point subtraction.
The subject’s reactive aggression was assessed using the number of
points he subtracted from the opponent on a winning trial
following a losing trial, with a certain level of provocation (HP/
LP). The game lasted 48 trials with a 1-minute break after 24
trials. Before the game started, the participants were asked if they
were nauseous and if they agreed to complete a short in-house
questionnaire on how they felt before and after the PSAG.
Data analysis
The normality of the data was analyzed using Kolmogorov–
Smirnov’s ‘Goodness of fit test.’ The point subtraction data in the
PSAG were normally distributed. Because of an explorative
approach significant p-values were not subjected to alpha-
adjustment. The level of statistic significance was set at p,0.05.
ATD/BAL intake effects on reactive aggression as a function of
provocation level and group were analyzed using a repeated
measures analysis of variance (RMANOVA) with group (ADHD/
controls), treatment (ATD/BAL), and provocation (HP/LP) as
factors. Additional post-hoc analyses (t-tests for additional within-
group comparisons of point subtraction under ATD and BAL) and
between-group comparisons of descriptive sample characteristics
data (Table 1) were performed. The relationship between trait-
impulsive characteristics, as assessed by the BIS, and reactive
aggression under ATD was examined using Spearman rank
correlations (Rho) between MI, CI, UI and the difference in point
subtraction from ATD to BAL intake (D=Delta) for both
provocation levels (DLP, DHP). Spearman’s rank correlations
(Rho) were used because they are very robust to outliers, as the
analysis of data is independent of its distribution and the
correlation coefficient is invariant to transformation. Potential
effects of diagnostic characteristics (age, IQ, diagnosis, and BIS
total impulsivity) on point subtraction (HP/LP) were controlled for
using a two-way analysis of covariance with repeated measures
(RMANCOVA) with the characteristics as covariates. The
RMANCOVA was non-significant for all covariates. We also
tested for potential order effects (ATD on day 1 vs. ATD on day 2)
on point subtraction (HP/LP) in the whole sample. A two-way
RMANOVA (with ATD on day 1 vs. day 2 as a between-subject
factor) performed for this purpose showed no significance (the
interaction effect for ATD administration and HP/LP; F=0.059,
p=n.s., df=1, 39). Moreover, there were no significant differences
between the different groups of patients who received different
medications for treatment of ADHD symptoms before the study
on point subtraction as a function of treatment (ATD/BAL) or
provocation (LP/HP) as indexed by a RMANOVA with no
significant medication group 6treatment (ATD/BAL) interaction
(p=n.s., F=0.113, df=1, 39). We calculated Cohen’s d values for
each level of provocation (HP/LP) as an estimate for effect sizes
with respect to detecting a difference in mean point subtraction
under ATD between groups, indicating a moderate effect sizes for
both provocation levels (dHP=0.438; dLP=0.646). Based on the
calculated effect sizes we also conducted a post-hoc power analysis
using G Power Software (University of Kiel) in order to determine
the statistical power of the completed experiment. We detected a
power (1-b err prob) of 0.99 for the LP condition and a power of
0.97 for HP trials to detect significant between-subject differences
in means with an alpha level of 0.05 in a RMANOVA. Following
this, the present study was adequately powered.
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